top of page

Félicitations à nos 40 meilleures équipes de 2021/22!

158_SOCS Family Protein Responsible for Allergic Asthma T Cell Differentiation

158_SOCS Family Protein Responsible for Allergic Asthma T Cell Differentiation

91_Reprograming The Immune System to Fight Lung Cancer

91_Reprograming The Immune System to Fight Lung Cancer

196_Treg Cell Therapy: A Novel Treatment for Pulmonary Arterial Hypertension

196_Treg Cell Therapy: A Novel Treatment for Pulmonary Arterial Hypertension

155_Using Prime Editing to Correct Cystic Fibrosis Mutations

155_Using Prime Editing to Correct Cystic Fibrosis Mutations

120_LDL gene-specific variation on increased atherosclerotic risk in South Asians

120_LDL gene-specific variation on increased atherosclerotic risk in South Asians

25_Preventing atrial fibrillation in hypertrophic cardiomyopathy using ACEIs and ARBs

25_Preventing atrial fibrillation in hypertrophic cardiomyopathy using ACEIs and ARBs

110_Investigating the correlation between Vitamin-D3 and the progression of ATTR-CM

110_Investigating the correlation between Vitamin-D3 and the progression of ATTR-CM

170_Exploring a Stereolithography Machine’s Ability to Bio-print Cardiac Tissue

170_Exploring a Stereolithography Machine’s Ability to Bio-print Cardiac Tissue

132_Evaluating the Utility of Tenecteplase-coated Magnetic Nanoparticles in Treating Ischemic Stroke

132_Evaluating the Utility of Tenecteplase-coated Magnetic Nanoparticles in Treating Ischemic Stroke

Group 138 - IgNITE Medical Case Competition 2022 (Rida Zaidi, Fajjar Aqeel)

Group 138 - IgNITE Medical Case Competition 2022 (Rida Zaidi, Fajjar Aqeel)

119_Inhibition of miR-150-5p decreases cardiac fibrosis in diabetic rats

119_Inhibition of miR-150-5p decreases cardiac fibrosis in diabetic rats

Group #152-The effects of raloxifene promoted angiogenesis on adaptive cardiac hypertrophy

Group #152-The effects of raloxifene promoted angiogenesis on adaptive cardiac hypertrophy

36_Development of non-invasive RNA therapy for drug-resistant cystic fibrosis mutations

36_Development of non-invasive RNA therapy for drug-resistant cystic fibrosis mutations

136_Identification of Atherosclerosis-Promoting Genes in the CD36/JNK/AP1 Pathway

136_Identification of Atherosclerosis-Promoting Genes in the CD36/JNK/AP1 Pathway

40_Butyrylcholinesterase in the Pathogenesis of Sudden Infant Death Syndrome

40_Butyrylcholinesterase in the Pathogenesis of Sudden Infant Death Syndrome

113_Exosome-based delivery of Pip4k2c modRNA to prevent Cardiac Fibrosis

113_Exosome-based delivery of Pip4k2c modRNA to prevent Cardiac Fibrosis

147 Inhibitory Effects of Opioids on Cardiac Ion Channels During Pregnancy

147 Inhibitory Effects of Opioids on Cardiac Ion Channels During Pregnancy

208_Congenital Heart Disease: Maternal ADIPOQ Polymorphism and High Nitrite Diet

208_Congenital Heart Disease: Maternal ADIPOQ Polymorphism and High Nitrite Diet

166_Investigating TGF-β and Transient Endothelial Cell Plasticity after Myocardial Infarction

166_Investigating TGF-β and Transient Endothelial Cell Plasticity after Myocardial Infarction

195_Investigating the correlation of cor pulmonale in Cystic Fibrosis mutations

195_Investigating the correlation of cor pulmonale in Cystic Fibrosis mutations

73_Inhaled Liposome-Packaged Oncolytic Viruses for Treatment of Lung Cancer

73_Inhaled Liposome-Packaged Oncolytic Viruses for Treatment of Lung Cancer

117_Novel decoy gene therapy for Marfan Syndrome targeting AP-1

117_Novel decoy gene therapy for Marfan Syndrome targeting AP-1

70_Reducing Post-Ischemic Stroke Injury By Silencing FasL, TNFR-1, and Calpain

70_Reducing Post-Ischemic Stroke Injury By Silencing FasL, TNFR-1, and Calpain

148_Investigating SHP and PCSK9 interactions in cholesterol-mediated cardiovascular diseases

148_Investigating SHP and PCSK9 interactions in cholesterol-mediated cardiovascular diseases

153_Using CRISPRi to downregulate TGFβ1 in COPD mouse models

153_Using CRISPRi to downregulate TGFβ1 in COPD mouse models

179_Lipid Nanoparticle delivery of CRISPR-Cas 9 for Alpha-1 Antitrypsin Deficiency

179_Lipid Nanoparticle delivery of CRISPR-Cas 9 for Alpha-1 Antitrypsin Deficiency

19-L'édition du gène ITPKC empêche la régulation négative de l’activation des lymphocytes T

19-L'édition du gène ITPKC empêche la régulation négative de l’activation des lymphocytes T

60_Potential of MenSCs to Recover Damaged Myocardium in Cardiac Disease

60_Potential of MenSCs to Recover Damaged Myocardium in Cardiac Disease

Optimal control of MOG1 drug gene therapy in Brugada syndrome

Optimal control of MOG1 drug gene therapy in Brugada syndrome

104_Reducing myocardial reperfusion injury via SERCA stimulation and NKA inhibition

104_Reducing myocardial reperfusion injury via SERCA stimulation and NKA inhibition

93_Novel Methods for Reduction of Stent Thrombosis Using 3D-Bioprinted Drug Eluting Stents

93_Novel Methods for Reduction of Stent Thrombosis Using 3D-Bioprinted Drug Eluting Stents

Group72 - Inhibition of TBF-β to Prevent Cell Proliferation in Marfan Syndrome

Group72 - Inhibition of TBF-β to Prevent Cell Proliferation in Marfan Syndrome

54_Sonic Machine Learning Evaluation System for Interstitial Lung Disease Diagnosis

54_Sonic Machine Learning Evaluation System for Interstitial Lung Disease Diagnosis

75_Nano-encapsulated mycobacteriophages as an anti-Tuberculosis therapy

75_Nano-encapsulated mycobacteriophages as an anti-Tuberculosis therapy

197_GRK Mediated B2 Desensitization 197 GRK Mediated B2 Desensitization

197_GRK Mediated B2 Desensitization 197 GRK Mediated B2 Desensitization

190_Suppression of Atherosclerosis by CRISPR-Cas9-Mediated Knockout of CD47

190_Suppression of Atherosclerosis by CRISPR-Cas9-Mediated Knockout of CD47

118_InflammatoryMarkersinSubclinicalExercise-inducedArrhythmogenicRightVentricularCardiomyopathy

118_InflammatoryMarkersinSubclinicalExercise-inducedArrhythmogenicRightVentricularCardiomyopathy

22_Investigating NF-kB Inhibition as Potential Epithelial-Mesenchymal Transition and NSCLC Treatment

22_Investigating NF-kB Inhibition as Potential Epithelial-Mesenchymal Transition and NSCLC Treatment

45_The Characterization of Kawasaki Disease-Specific Genes using CRISPR-Cas9

45_The Characterization of Kawasaki Disease-Specific Genes using CRISPR-Cas9

Direct diagnosis of LTBI using Rv0081 lateral flow assays [IgNITE Elevator Pitch]

Direct diagnosis of LTBI using Rv0081 lateral flow assays [IgNITE Elevator Pitch]

** Les 40 meilleures équipes sont présentées dans un ordre aléatoire. L'ordre des vidéos n'indique pas une position spécifique dans la compétition.

bottom of page